Table 2.

The Overall Survival (OS) at 5 years in each subgroup population with OSCC.

		OS at 5 years (95%CI)	p value*
gender	male	0.326 (0.257, 0.413)	0.547
	female	0.384 (0.283, 0.52)
age	≤60 yr	0.298 (0.221, 0.402)	0.851
	>60 yr	0.402 (0.319, 0.505)
smoking	never	0.339 (0.266, 0.431)	0.624
	ever	0.349 (0.258, 0.473)
drinking	never	0.336 (0.261, 0.433)	0.742
	ever	0.355 (0.267, 0.471)
primary site	cheek	0.408 (0.262, 0.637)	0.176
	tongue	0.33 (0.232, 0.471)
	gum	0.331 (0.223, 0.492)
	others	0.318 (0.224, 0.451)
cell differentiation	high	0.336 (0.264, 0.429)	0.33
	moderate	0.408 (0.298, 0.558)
	low	0.252 (0.13, 0.49)
tumor stage	T1	0.397 (0.26, 0.606)	0.068
	T2	0.399 (0.311, 0.512)
	T3	0.295 (0.179, 0.486)
	T4	0.243 (0.145, 0.409)
nodal stage	N0	0.451 (0.364, 0.56)	<0.001
	N1-3	0.238 (0.171, 0.332)
clinical TMN stage	I	0.58 (0.425, 0.791)	0.001
	II	0.413 (0.301, 0.566)
	III	0.26 (0.181, 0.375)
	IV	0.259 (0.155, 0.434)
c-Jun	Low expression	0.555 (0.445, 0.693)	<0.001
	High expression	0.258 (0.193, 0.345)
Fra-1	Low expression	0.543 (0.45, 0.655)	<0.001
	High expression	0.191 (0.13, 0.282)

^* p value was generated using log-rank test.